November 3, 2025 — Leads & Copy — Caribou Biosciences, Inc. (Nasdaq: CRBU) announced that management will participate in investor conferences including the 2025 Truist Securities BioPharma Symposium in New York on November 6, 2025, and the 8th Annual Evercore Healthcare Conference in Coral Gables, FL on December 2, 2025, with a fireside chat at 8:45-9:05 AM ET.
Webcasts will be available on Caribou’s website for at least 30 days after the event.
Caribou Biosciences is focused on developing transformative therapies for devastating diseases using its CRISPR genome-editing platform. Caribou is focused on vispacabtagene regedleucel (vispa-cel) and CB-011 as off-the-shelf CAR-T cell therapies that have the potential to provide broad access and rapid treatment for patients with hematologic malignancies.
Peggy Vorwald, PhD, can be reached at media@cariboubio.com or investor.relations@cariboubio.com
Source: Caribou Biosciences, Inc.
Source: Caribou Biosciences, Inc.
